Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
- PMID: 35385633
- PMCID: PMC8987689
- DOI: 10.4093/dmj.2021.0329
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Abstract
Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past 30 years. In order to reduce disease prevalence, extensive research has been ongoing to improve prediction of DKD onset and progression. Although the most commonly used markers of DKD are albuminuria and estimated glomerular filtration rate, their limitations have encouraged researchers to search for novel biomarkers that could improve risk stratification. Considering that DKD is a complex disease process that involves several pathophysiologic mechanisms such as hyperglycemia induced inflammation, oxidative stress, tubular damage, eventually leading to kidney damage and fibrosis, many novel biomarkers that capture one specific mechanism of the disease have been developed. Moreover, the increasing use of high-throughput omic approaches to analyze biological samples that include proteomics, metabolomics, and transcriptomics has emerged as a strong tool in biomarker discovery. This review will first describe recent advances in the understanding of the pathophysiology of DKD, and second, describe the current clinical biomarkers for DKD, as well as the current status of multiple potential novel biomarkers with respect to protein biomarkers, proteomics, metabolomics, and transcriptomics.
Keywords: Biomarkers; Diabetic nephropathies; Inflammation; Metabolomics; Oxidative stress; Pathophysiology; Proteomics.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8987689/bin/dmj-2021-0329f1.gif)
Similar articles
-
Novel biomarkers for prognosticating diabetic kidney disease progression.Int Urol Nephrol. 2023 Apr;55(4):913-928. doi: 10.1007/s11255-022-03354-7. Epub 2022 Oct 22. Int Urol Nephrol. 2023. PMID: 36271990 Free PMC article. Review.
-
Novel biomarkers for diabetic kidney disease.Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S46-S62. doi: 10.23876/j.krcp.22.084. Epub 2022 Sep 30. Kidney Res Clin Pract. 2022. PMID: 36239061 Free PMC article.
-
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.Curr Diab Rep. 2021 May 11;21(7):21. doi: 10.1007/s11892-021-01390-8. Curr Diab Rep. 2021. PMID: 33974145 Free PMC article. Review.
-
Novel biomarkers of diabetic kidney disease: current status and potential clinical application.Acta Diabetol. 2021 Jul;58(7):819-830. doi: 10.1007/s00592-020-01656-9. Epub 2021 Feb 2. Acta Diabetol. 2021. PMID: 33528734 Review.
-
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.BMC Nephrol. 2020 Jun 29;21(1):242. doi: 10.1186/s12882-020-01901-x. BMC Nephrol. 2020. PMID: 32600374 Free PMC article.
Cited by
-
[Exercise promotes irisin expression to ameliorate renal injury in type 2 diabetic rats].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Apr 20;44(4):675-681. doi: 10.12122/j.issn.1673-4254.2024.04.08. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38708500 Free PMC article. Chinese.
-
Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning.Front Immunol. 2024 Feb 8;15:1332279. doi: 10.3389/fimmu.2024.1332279. eCollection 2024. Front Immunol. 2024. PMID: 38390317 Free PMC article.
-
Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy.J Microbiol Biotechnol. 2024 Mar 28;34(3):547-561. doi: 10.4014/jmb.2310.10028. Epub 2023 Dec 26. J Microbiol Biotechnol. 2024. PMID: 38346799 Free PMC article.
-
Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease.BMC Nephrol. 2024 Jan 24;25(1):32. doi: 10.1186/s12882-024-03471-8. BMC Nephrol. 2024. PMID: 38267859 Free PMC article.
-
Role of MCP-1 as an inflammatory biomarker in nephropathy.Front Immunol. 2024 Jan 4;14:1303076. doi: 10.3389/fimmu.2023.1303076. eCollection 2023. Front Immunol. 2024. PMID: 38239353 Free PMC article. Review.
References
-
- Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514–23. - PubMed
-
- Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361–77. - PubMed
-
- Kidney Disease: Improving Global Outcomes (KDIGO) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous